Viral Vector and Plasmid DNA Manufacturing Industry Research Report 2023 – Global Forecast to 2028 – Ongoing Research on Viral Vector-Based Cell and Gene Therapies to Drive Growth

Dublin, June 28, 2023 (GLOBE NEWSWIRE) — The report “Viral Vector and Plasmid DNA Manufacturing Market – Global Forecast to 2028” has been added to ResearchAndMarkets.com offer.

The global viral vector and plasmid DNA manufacturing market is projected to reach US$12.8 billion by 2028 from US$5.5 billion in 2023, at a CAGR of 18.2%.

The growth of this market can be attributed to the availability of funding for gene therapy development. Gene therapy is a rapidly growing field and funding is needed for research and development, clinical trials and manufacturing.

For example, in December 2022, SonoThera, a biotechnology company, announced the completion of its $60.75 million Series A funding round. The funding will support the continued development of SonoThera’s ultrasound-guided, non-viral gene therapy platform and treatments, designed to deliver genetic medicines to patients.

The carrier Amplification, Modification and Expansion segment accounted for the largest share of the upstream manufacturing process during the forecast period

In 2022, the vector amplification, editing and expansion segment accounted for the largest share by upstream manufacturing process in the global viral vector and plasmid DNA manufacturing market. Vector amplification, editing and expansion are critical steps in the production of viral vectors and plasmid DNA as they have a direct impact on the quantity, quality and functionality of the vectors.

The pharmaceutical and biopharmaceutical industry is seeing significant progress, especially in the development of new therapies and vaccines. Viral vectors and plasmid DNA are crucial tools for delivering therapeutic genes or vaccine antigens.

The demand for vector amplification, modification and expansion is driven by the need to produce a broad range of viral vectors and plasmid DNAs for various therapeutic and vaccine candidates.

Europe: The second largest region in the market for the production of viral vectors and plasmid DNA

Europe accounted for the second largest market for viral vector and plasmid DNA production market after North America. The European market for the production of viral vectors and plasmid DNA has experienced significant growth in recent years, driven by various factors that have favored its expansion.

Europe is at the forefront of the development and adoption of emerging technologies in the field of viral vector and plasmid DNA production market. This includes advances in viral vector and plasmid DNA production technologies. The adoption of these innovative technologies accelerates the progress of research on the production of viral vector and plasmid DNA and expands their applications.

In addition, Europe offers comprehensive training and education programs in the production of viral vectors and plasmid DNA. Universities, research institutes and organizations provide funding and conferences to improve the knowledge and skills of scientists and researchers.

The availability of funding promotes the adoption and use of viral vectors and plasmid DNA production technologies in Europe.

Key Attributes:

Ratio attribute Details
No. of pages 317
Forecast period 2023 – 2028
Estimated market value (USD) in 2023 $5.5 billion
Projected market value (USD) by 2028 $12.8 billion
Compound annual growth rate 18.2%
Regions covered Global

Premium insights

  • Ongoing research on viral vector-based cell and gene therapies to lead the market
  • The products segment in the United States accounted for the largest market share in 2022
  • Product segmentation to witness the highest growth rate during the forecast period
  • The pharmaceutical and biopharmaceutical companies segment accounted for the largest market share in 2022
  • China is set to register the highest CAGR during the forecast period

Market dynamics

Drivers

  • Increased prevalence of genetic diseases, cancer and infectious diseases
  • Availability of funding for the development of gene therapy
  • Efficacy of viral vectors
  • Ongoing research on viral vector-based cell and gene therapies

Restrictions

  • High operational costs associated with the production of cell and gene therapies
  • Short shelf life of viral vectors

Opportunity

  • Smart Capital Deployment and Planning for Scalability
  • Leverage digital tools to facilitate operational excellence

Challenges

  • Risk of mutagenesis and other undesirable outcomes
  • Individual optimization and low yield

Analysis of indicative prices

Value chain analysis

  • Value chain analysis: Production steps add the most value
  • Ecosystem analysis

Technology analysis

  • Examples of advanced products/platforms

Patent analysis

  • Top Patent Holders in Viral Vector and Plasmid DNA Manufacturing Market, January 2014 to January 2023
  • Examples of recent patent activity in the viral vector and plasmid DNA manufacturing market

Trends/disruptions impacting customer business

  • Revenue shift and new revenue pockets for viral vector and plasmid DNA manufacturers

Regulatory analysis

Company profiles

Key companies

  • Lonza Group
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • Wuxi Apptec Co. Ltd.
  • Fujifilm Corporation
  • Genscript Biotech Corporation
  • Takara Bio Inc.
  • Biomedical Oxford
  • Novartis Ag
  • Precision biosciences
  • Bluebird Bio, Inc.
  • Sartorio Ag
  • Danher Corporation
  • Sirion Biotech

Other players

  • Vgxi, Inc.
  • Waisman bioproduction
  • Kaneka Eurogentec SA
  • Plasmidfactory GmbH
  • Atum
  • Addgen
  • Catapult for cell and gene therapy
  • Batavia Biosciences BV
  • High-growing biosystems

For more information about this report, please visit https://www.researchandmarkets.com/r/pq4k1u

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We bring you the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

  • Viral vector production market


        

#Viral #Vector #Plasmid #DNA #Manufacturing #Industry #Research #Report #Global #Forecast #Ongoing #Research #Viral #VectorBased #Cell #Gene #Therapies #Drive #Growth
Image Source : www.globenewswire.com

Leave a Comment